ChipAgents Raises $74M to Scale an Agentic AI Platform to Accelerate Chip Design
17.2.2026 16:00:00 CET | Business Wire | Press release
Company opens 20,000 sq ft HQ in Silicon Valley to deploy AI Agents to accelerate chip design workflows. Sandeep Bharathi joins Advisory Board.
ChipAgents, the category leader for Agentic AI platforms in the semiconductor design industry, announced it has closed an oversubscribed $50 million Series A1 funding round, bringing total capital raised to $74 million. The round was led by Matter Venture Partners, a TSMC-backed HardTech VC firm, with participation from existing investors Bessemer Venture Partners, Micron, MediaTek, and Ericsson.
As part of the investment, Wen Hsieh, Founding Managing Partner of Matter VP, will join ChipAgents' Board of Directors, bringing over two decades of expertise and relationships in semiconductor design and manufacturing.
Building the AI Workforce for Chip Design Companies
This new capital will enable ChipAgents to aggressively scale its Agentic AI platform, expand its engineering and research organization, and accelerate global deployment of multi-agent chip teams. ChipAgents is building the foundational AI infrastructure for chip design, with coordinated AI Agents that can plan, reason, execute, and continuously improve across complex silicon programs. By transforming chip development into an AI-native, outcome-driven system, ChipAgents is redefining semiconductor innovations.
“We’re building an Agentic AI workforce for the semiconductor industry,” said William Wang, CEO and Founder of ChipAgents. “Our multi-agent AI teams are not just copilots or AI assistants; they actually take ownership. They read specifications, break down objectives, discuss and implement solutions, validate results, and iterate relentlessly. This is not incremental productivity software. It’s a revolutionary AI execution platform for silicon design.”
“As chip complexity explodes and experienced chip design talent becomes the limiting factor, the future will belong to hybrid human-AI teams with the best AI Agent infrastructure,” Wang added. “ChipAgents enables small IC design teams to operate like much larger organizations that can move at startup speed. This funding accelerates our mission to make AI-driven chip innovations the default model for how all silicon will be designed, built, and shipped.”
Strategic Partnership with Industry Leaders
The investment by Matter Venture Partners, a VC firm with deep roots across the global semiconductor ecosystem, reinforces confidence in ChipAgents’ vision to build the Agentic AI platform powering the next generation of silicon innovation. With leading foundries fabricating the vast majority of the world’s most advanced chips, alignment with investors embedded in this ecosystem positions ChipAgents at the center of a structural shift toward AI-native chip development.
"The semiconductor industry is entering a phase where the limits to chip design productivity are no longer the tools themselves," said Wen Hsieh, Founding Managing Partner of Matter Venture Partners. "The limits are now talent availability, human bandwidth and design iteration speed. ChipAgents addresses this constraint directly with an Agentic AI platform capable of significantly scaling engineering and design capacity alongside advanced manufacturing progress. As the AI ecosystem demands increasingly complex, higher-performing silicon, we believe ChipAgents will be essential for any chip company that wants to shape the future of AI and compute.”
Market Momentum and Customer Traction
Building on the momentum of its Series A that was completed a few months ago, ChipAgents has achieved 140x year-over-year ARR growth and has expanded deployments to 80 leading semiconductor companies, securing several multi-year, multi-million-dollar licensing agreements. The team has scaled from 10 to 46 employees and relocated its headquarters from Santa Barbara to a new state-of-the-art facility in Santa Clara, placing the company at the center of the global semiconductor ecosystem. Across Tier-1 semiconductor programs in live production environments, ChipAgents is delivering step-function performance gains:
- 15x faster specification reading and comprehension
- 240x reduction in formal assertion generation time
- 100% code and functional coverage through formal verification
- 400x faster UVM environment generation
These results translate into significantly compressed verification cycles, full design visibility, and a new level of execution velocity across complex digital IC design programs, enabling teams to ship more silicon with greater speed, confidence and control.
World-Class Advisory Board Expands
Sandeep Bharathi, President of Marvell’s Data Center Group, joined ChipAgents’ Advisory Board, bringing over two decades of experience leading chip development for hyperscale cloud and enterprise infrastructure. His expertise in scaling complex SoC programs from design through high-volume production will help guide ChipAgents through its rapid growth.
“Semiconductor development continues to grow in complexity as systems scale across cloud and enterprise infrastructure. The industry must rethink how engineering teams are supported. ChipAgents is exploring how AI can create design and verification workflows, and I look forward to advising the company as it advances this mission,” said Sandeep Bharathi.
Bharathi joins an advisory board that already includes Wally Rhines, former CEO of Mentor Graphics (now Siemens EDA); Raúl Camposano, former CTO of Synopsys; Jack Harding, former CEO of Cadence; John Bowers, Electrical Engineering pioneer, and Erez Tsur, former CEO of Cadence Israel.
About ChipAgents
ChipAgents is an Agentic AI platform that transforms specifications and code into production-ready RTL, verification assets, and automated root-cause analysis, dramatically shortening design and verification cycles. Founded in 2024, the company brings autonomous AI Agents into production semiconductor workflows, serving both design and verification engineers and embedded systems teams at leading semiconductor companies worldwide. The company is headquartered in Santa Clara, California. For more information, visit chipagents.ai
About Matter Venture Partners
Matter Venture Partners is a Silicon Valley-based venture capital firm backing exceptional founders building the most advanced semiconductor, electronics, and Physical AI innovations. With decades of operational expertise and deep strategic relationships, Matter Venture Partners pairs technical insight with long-term conviction to help scale category-defining HardTech startups.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260217568914/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kiabi Selects Navan to Centralise Global Travel Program11.5.2026 09:00:00 CEST | Press release
Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Kiabi, the French multinational fashion retailer, to consolidate its global travel with one unified platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511547434/en/ Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform To support its workforce of nearly 10,000 “Kiabers,” the retailer required a solution capable of providing an easy-to-use travel platform. Navan was selected due to its intuitive AI-powered interface and ability to integrate with Kiabi’s travel policies directly in-app. “Managing travel was becoming an administrative burden that slowed our teams down,” said Denise Maurice, Indirect Procurement Director at Kiabi. “We wanted to give our ‘Kiabers’ the
Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland11.5.2026 09:00:00 CEST | Press release
Partnership aims to reduce the ‘meeting tax’ by expanding access to Owl Labs products through Westcoast’s extensive distribution network Owl Labs, a global leader in AI-powered, 360-degree video conferencing solutions, today announced a new UK and Ireland distribution partnership with Westcoast Limited, one of the country’s largest and most trusted IT distributors. The agreement will see Westcoast distribute the full range of Owl Labs’ award-winning Meeting Owl and Owl Bar products across the UK and Ireland, providing greater choice, availability, and dedicated support for resellers and end customers navigating the demands of hybrid work. The partnership aims to address the technical setup challenges that plague meetings across the UK. Owl Labs’ recent State of Hybrid Work report found that nearly 8 in 10 workers (79%) lose time in meetings due to technical difficulties such as connecting to a meeting or setting up a camera. By making Owl Labs’ solutions simpler to source, deploy and s
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay11.5.2026 09:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA). “With Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma now CE‑marked on our LUMIPULSE G platform, we are advancing a new era of neurology diagnostics—one where blood‑based biomarkers enable earlier, broader, and more accessible insights into Alzheimer’s disease and neurodegeneration.” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “By delivering fully automated and scalable solutions, we are helping clinicians move decisively toward more timely and informed decision‑making. This milestone underscores our long‑term vision to reimagine the diagnostic
Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 202611.5.2026 08:00:00 CEST | Press release
The MEVION S250-FIT™ creates a new pathway for European cancer centers to integrate proton therapy into existing radiotherapy programs Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507172087/en/ The MEVION S250-FIT™ Proton Therapy System Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, aligning advanced proton capability with the infrastructure, workflows, and capital planning of modern radiation oncology. Stanford Medicine: First S250-FIT Installation On April 7, 2026, Stanford Medicine unveiled
Vedanta FY26 Profit Soars by 22% to $2.8 bn; Enters Demerger Phase11.5.2026 02:30:00 CEST | Press release
India-based Vedanta Limited (BSE: 500295 & NSE: VEDL), a global leader in metals, oil & gas, critical minerals, power and technology, announced its results for the fourth quarter and full year ended 31 March 2026. It has delivered its best-ever financial performance, driven by structurally strong businesses and disciplined execution. For the full year, Vedanta’s Profit stood at an all-time high of $2.8 bn, reflecting a 22% YoY increase and a profit of $1 bn in Q4 FY26, up nearly 90% YoY. Vedanta reported its highest-ever annual revenue of about $20 bn, up 15% YoY, with Q4 revenue at $5.6 bn, an increase of nearly 30% YoY. The Company maintained strong cost leadership, contributing to record EBITDA of $6.3 bn for FY26, up by about 30% YoY, with margins expanding to around 40%. Q4 EBITDA stood at $2.0 bn, up by nearly 60% YoY, with a margin of approximately 44%. The balance sheet strengthened further, with Net Debt/EBITDA improving to 0.95x, supported by strong cash generation. Underscor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom